🇺🇸 FDA
Patent

US 8748648

Oligomer-calcium channel blocker conjugates

granted A61KA61K31/4418A61K31/4422

Quick answer

US patent 8748648 (Oligomer-calcium channel blocker conjugates) held by Nektar Therapeutics expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/4418, A61K31/4422, A61K47/60, A61P